Baker Biotech Capital (GP), LLC Insider Trading $TZYM Ocera Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Baker Biotech Capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Baker Biotech Capital (GP), LLC. Baker Biotech Capital (GP), LLC is 10% Owner in PHARMACYCLICS INC ($PCYC) and 10% Owner in VIROPHARMA INC ($VPHM) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in ADOLOR CORP ($ADLR) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in Ocera Therapeutics, Inc. ($TZYM).
Baker Biotech Capital (GP), LLC in Ocera Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Biotech Capital (GP), LLC: 10% Owner
Holdings: 232,011 shares
Latest Transaction: Mar 14 2012
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Baker Biotech Capital (GP), LLC in Ocera Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADLR, GHDX, TZYM, PCYC, SGEN, GEVA, VPHM
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 14 2012 | TZYM | Ocera Therapeutics ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 3.01 | 4,592 | 13,801 | 232,011 | 227.4 K to 232 K (+2.02 %) |
| Mar 14 2012 | TZYM | Ocera Therapeutics ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 2.99 | 7,484 | 22,370 | 227,419 | 219.9 K to 227.4 K (+3.40 %) |
| Mar 14 2012 | TZYM | Ocera Therapeutics ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 2.96 | 15,599 | 46,143 | 219,935 | 204.3 K to 219.9 K (+7.63 %) |
| Mar 14 2012 | TZYM | Ocera Therapeutics ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 2.55 | 56,187 | 143,277 | 204,336 | 148.1 K to 204.3 K (+37.93 %) |
| Mar 14 2012 | TZYM | Ocera Therapeutics ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 2.34 | 32,155 | 75,230 | 148,149 | 116 K to 148.1 K (+27.72 %) |
| Mar 14 2012 | TZYM | Ocera Therapeutics ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 1.87 | 4,363 | 8,159 | 115,994 | 111.6 K to 116 K (+3.91 %) |
| Mar 14 2012 | TZYM | Ocera Therapeutics ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 1.89 | 1,601 | 3,019 | 111,631 | 110 K to 111.6 K (+1.46 %) |
Page: 1